ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 698

Grip Strength Identifies Increased Physical Disability in Women with Systemic Lupus Erythematosus

James S. Andrews1, Mary Margaretten2, Jennifer Barton2, Jinoos Yazdany2, Ed Yelin2 and Patricia P. Katz3, 1Rheumatology, University of California San Francisco, San Francisco, CA, 2Medicine, University of California, San Francisco, San Francisco, CA, 3Medicine, University of California, San Francisco, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: grip strength and physical function, Lupus

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Treatment and Management Studies

Session Type: Abstract Submissions (ACR)

Background/Purpose: Muscle weakness is common and contributes to physical disability in women with systemic lupus erythematosus (SLE). Recently, the Foundation for the National Institutes of Health Sarcopenia Project reported grip strength cutpoints that identified weakness associated with impaired mobility among women aged ≥ 65 years.   However, the ability of grip strength to identify SLE patients at increased risk of physical disability is unknown.  This study aims to test whether grip strength is associated with increased physical disability in women with SLE. 

Methods: Subjects were women in a longitudinal cohort with physician-documented SLE.  All measures were collected during an in-person research visit among a subset of the cohort.  Grip strength was measured with a handheld dynamometer.  Grip strength was classified as “weak” (<16kg), “intermediate” (16-20kg), and “normal” (>20kg).  Self-reported physical functioning was assessed using the SF-36 Physical Functioning subscale (range 0-100, mean 50, SD 10) and Valued Life Activities (VLA) Disability (range 0-3) surveys.  Higher SF-36 and lower VLA scores indicate higher functioning. Regression analyses controlling for age, SLE duration, prednisone use, SLE disease activity measured with the Systemic Lupus Activity Questionnaire (SLAQ), physical activity level measured by the International Physical Activity Questionnaire (IPAQ), and depressive symptoms measured by the Center for Epidemiological Studies Depression Scale (CES-D) modeled the effects of grip strength on SF-36 and VLA scores. 

Results: Of the 146 women, mean age was 48 (±12) years; duration of SLE was 16 (±9) years; SF-36 score was 40.9 (±11.4); VLA disability score was 0.80 (±0.55).  Fifteen women (10%) had “weak” grip strength, 31 (21%) “intermediate, 78 (53%) “normal”; and 22 (15%) were missing grip strength data.  In both unadjusted and adjusted models, having “weak” compared to “normal” grip strength was associated with significantly worse SF-36 and VLA scores (see Table 1).  In sensitivity analyses examining the effects of missing grip strength data and of excluding women aged ≥ 65 years (n=11), the overall trends were unchanged. 

Conclusion:  Grip weakness was common in our cohort of women with SLE, with a prevalence comparable to that of geriatric populations.  Grip weakness successfully identified women with increased physical disability even when adjusting for potential confounders such as disease activity and depression.  These findings underscore the high burden of muscle weakness among women with SLE, and they may suggest a clinical role for grip strength testing in identifying women with SLE at greatest risk of physical disability.  Further studies will need to examine the ability of grip strength to predict incident disability in SLE.

Table 1. Association between Grip Strength and Disability Scores#

 

SF-36 Physical Functioning

Valued Life Activities

Unadjusted

Adjusted

Unadjusted

Adjusted

Weak

(<16kg)

-11.8 (-17.6, -6.1)***

-4.4 (-8.7, -0.1)*

0.68 (0.40, 0.96)***

0.31 (0.11, 0.51)**

Intermediate

(16-20kg)

-7.5 (-11.8, -3.2)**

-3.2 (-6.3, 0.01)

0.29 (0.08, 0.50)**

0.08 (-0.06, 0.23)

Normal

(>20kg)

ref.

ref.

ref.

ref.

#Values are regression beta coefficients (95% CI).  Grip strength cutpoints defined per Alley DE et al., J Gerontol A Biol Sci Med Sci 2014 May; 69(5):559–566. 

*p<0.05, **p<0.01, ***p<0.001













Disclosure:

J. S. Andrews,
None;

M. Margaretten,
None;

J. Barton,
None;

J. Yazdany,
None;

E. Yelin,
None;

P. P. Katz,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/grip-strength-identifies-increased-physical-disability-in-women-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology